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ADVANCING KNOWLEDGE, PROTECTING INFORMATION: PRECISION MEDICINE AND POPULATION
HEALTH RESEARCH IN HEALTH SYSTEMS

Raj C. Shah, Alissa Bugh, Mary Jane Welch, Andrew Reeder*

I. INTRODUCTION

In order to achieve the highest value for the resources spent on the provision of health care, the
delivery of health care in the United States must change. The health care enterprise in the United States
strives to reclaim global leadership in achieving better health care outcomes for a diverse and inclusive
population, better care experiences for individuals, and better use of resources for health and care. Achieving
these goals requires the transformation of the health care system into a learning health system where practice
influences research and research influences practice. Linking research with practice requires understanding
the health of large groups of individuals as well as understanding the health of single individuals – an idea that
is often described simply as “precision medicine.” Forces accelerating precision medicine include patient
partnerships, mobile technologies, genomics, data science, and electronic health records. Forces resisting
change include various laws created at times when technological advances did not exist. In this article, we
explore the tensions between technologies advancing large scale health data sharing and health data privacy
and security. We highlight potential evolutionary changes to help reconcile the tensions along with more
disruptive innovations.

II. BACKGROUND
Why Health Care Must Change

Health care in the United States needs to undergo significant changes. In the last almost 80 years, the
life expectancy at birth for women has increased from 65.2 years in 1940 to 80.1 years in 2003.1 For men, the
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life expectancy at birth has moved from 60.8 years in 1940 to 74.8 years in 2003.2 The total number of persons
over age 65 has increased from 9 million in 1940 to 47.8 million in 2015 and is projected to increase to 98.2
million by 2060.3 While life expectancy has increased, persistent gaps in health equity continue to be present
even though reduced. For instance, the difference in life expectancy at birth between black men and white
men was slightly above 7 years in 1970 but was still 6.3 years in 2003.4 The difference in life expectancy at
birth between women and men was 4.4 years in 1940 but had increased to 5.3 years by 2003.5 In a recent
report by the Commonwealth Fund comparing health care systems on dimensions of quality care, access,
efficiency, equity, and healthy lives, the United States far exceeded the remaining 10 developed nations with a
health expenditure per capita (in 2011 US dollars) of over $8,500 while the second closest nation (the
Netherlands) spent a little over $5,600.6 For that expenditure of resources, the United States received an
overall health care ranking of 11 while the United Kingdom received a ranking of 1.7 The highest ranking the
United States received was 3 out of 11 for effective care.8 These issues have led the United States over the
last 5 years to embark on achieving the “Triple Aim,” which includes: (1) better outcomes for the local
population, (2) better care and experience for individuals, and (3) better use of resources for health and care.9

How Can Health Care Change
In order to achieve the Triple Aim, health care must be transformed into a learning health system.10 In
a learning health care system, practice influences research and research influences practice. A continuous
cycle is needed for learning health systems to engage with their environments, adapt and find solutions.
Internal and external scans are required to identify problems. With the identification of problems that matter,
design of a solution plan is needed that can be implemented in pilot settings. Collecting data and analyzing
data can evaluate what works or does not work. The evidence generated leads to solution optimization in an
iterative process. Finally, solutions are shared broadly to improve care for everyone through informing policy.
The idea of a learning health system has been incorporated into a cyclical model of the United States Food
and Drug Administration (“FDA”) to optimize the cycle of driving discovery science to early translational steps
followed by clinical trials, clinical practice guidelines, performance measures, and outcomes.11
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Why Population Health Research

Most research to understand health and health care delivery focuses on information collected from subgroups. Results from limited samples then are extrapolated to the entire population using statistical
techniques. As a result, there is a higher chance for research to have external validity as the sample selected
may never fully represent the entire population. Cost of data collection is a large contribution to needing
sampling techniques in research. The closest data collection mechanism to engage every potential person in
the United States is the US Census. Written into the US Constitution and required to be conducted every 10
years, the attempt to count every single person in the United States had a cost of approximately $12 billion in
2010.12 However, the cost of using the US Census infrastructure even on an annual basis is dwarfed the
estimated $3.2 trillion spent by the US in health care in 2015.13 In addition, recent advances in science and
technology are now accelerating the ability to potentially understand larger populations in more detail using
very cost-efficient tools. These advances are tempered by forces opposing the growth of population health
research.

Forces Accelerating Change

Forces accelerating change include, but are not limited to, genomics, electronic health records, and
data sciences.
Gregor Mendel’s 1865 presentation on the laws governing the transmission of heritable traits in peas is
commonly viewed as the foundation of genetics as a scientific discipline.14 However, it took almost a century to
determine that DNA was the biologic structure governing inheritance.15 Further foundational work led to the
willingness to initiate the Human Genome Project in 1990 to characterize the DNA in human chromosomes,
including all genes. It took until 2003 for the human genome sequence to be completed.16 In 2003, the cost
associated with generating the first complete human genome sequence was estimated to be between $500
million and $1 billion dollars.17 With advances in technique in the last decade, the cost of sequencing the 23
chromosomes and 3 billion base-pairs of the human genome has dropped to about $1000 dollars.18 Currently,
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every person is able to submit a DNA sample to a commercial entity and for about $200 obtain their ancestry
and basic health information.19
In 2010, efforts significantly increased to digitize health care records. In 2008, there were no states
where the percent of non-federal acute care hospitals that had adopted at least a Basic Electronic Health
Record was over 60%.20 By 2014, all States had more than 60% of their non-federal acute care hospitals with
adoption of a basic electronic health record.21
The explosion of health data from multiple electronic sources along with sophisticated data science
tools to organize and analyze the data has led to the development of highly dimensional information. Within a
single person, we are able to understand various levels of information from the clinical data from medical
histories, the genome, the transcriptome, the proteome, the metabolome, and the microbiome.22 While the
genome represents an organism’s complete set of DNA including all of its genes, the transcriptome is the set
of all messenger RNA (the molecules that translate genes into proteins) in a single cell or population of cells
and the proteome is the entire set of proteins expressed by a genome in a given type of cell at a given time
under defined conditions. In addition to the detailed understanding of the pathways connecting DNA to
proteins, the metabolome refers to the complete set of small-molecule chemicals found within a biological
sample and the microbiome is the curation of microorganisms and their collective genetic material present in or
on the human body. Given that advanced tools and technology related to “-omics” are not able to process a
large number of samples in semi-automated or automated ways at a reduced expense, this level of detail on
large numbers of individuals can be collected effectively. Using data science and computing technologies, we
can analyze the network of relationships between these multiple layers along with relationships with community
level and environmental data sets.
These advances, in addition to mobile technologies and patient partnerships, have led to the National
Institutes of Health proposing the Precision Medicine Initiative to better appreciate how the connected, multilevel information can be utilized.23 Precision medicine is an emerging approach for prevention and treatment
of disease that takes into account people’s individual variations in genes, environment, and lifestyle.24 The
scientific evidence to move the precision medicine concept into clinical practice is underway. The All of Us
Research Program is one component of the Precision Medicine Initiative.25 It involves engaging over 1 million
volunteers residing in the United States who will share genetic data, biological samples, and diet/lifestyle
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information that can be linked with their electronic health records, if they choose.26 In this new model of doing
science through engaged participants, responsible data sharing, and privacy protection, the generalizable
knowledge from the cohort will (1) advance pharmacogenomics (the right drug for the right patient at the right
dose), (2) identify new targets for treatment and prevention, (3) test whether mobile devices can encourage
healthy behaviors, and (4) lay a scientific foundation for precision medicine for many diseases, common and
rare.27 The National Evidence Generation Infrastructure by the United States FDA also is being proposed to
link data from multiple sources with the National Institutes of Health (“NIH”), the Patient-Centered Outcomes
Research Institute (“PCORI”), the Centers for Disease Control and Prevention (“CDC”), and industry to impact
medical product safety surveillance.28

Forces Resisting Change

In the movement towards greater health data utilization for research, forces resisting change include
various laws created at times when technological advances did not exist. Before the Health Insurance
Portability and Accountability Act (“HIPAA”) was signed into law in 1996, there was not a patient privacy
standard at the federal level for Protected Health Information.29 HIPAA simplified the administrative processes
for health data transfer for health care treatment, operations, and payments and provided administrative,
physical and technical safeguards for Protected Health Information.30 Through the passage of the American
Recovery and Reinvestment Act – Health Information Technology for Economic and Clinical Health
(“HITECH”), the HIPAA Privacy Rule was extended to include new civil penalties for violations, to have covered
entities and business associated comply, and to establish breach notification obligations in an Act mainly
designed to provide specific incentives to accelerate the adoption of electronic health record systems among
providers.31 With the introduction of Meaningful Use guidelines for Electronic Health Records in 2010 by the
Centers for Medicare and Medicaid Services (“CMS”), the conducting of a security risk analysis was added in
the list of compliance measures for which health systems could obtain incentives.32
While the laws and regulations helped with clinical care processes, they made the connection of data
from clinical care to research more difficult. A report from the Institute of Medicine Committee in 2009
concluded that the HIPAA Privacy Rule does not protect privacy as well as it should and impedes important
health research.33 Also, the lack of an overall coordination between federal level privacy laws and regulations
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along with varying state laws and regulations creates a complex and sometimes contradictory set of rules to
follow when conducting population health studies in many states.

III. TENSIONS

The factors accelerating population health research and those resisting change create a tension that
requires resolution.34 Each person has a “data privacy meter” that goes from not minding who has access to
their personal health data to wanting tight control over their data at all times. Where someone sits on the
meter can vary by social climate, personal risk tolerance, and by the type of data being shared. While there is
significant support for open data for solving health issues, there is a countering force of ensuring a high level of
privacy controls. This leads to the untenable situation where perfect privacy is only obtained when no data is
shared or where open access for health research for societal benefit leads to complete loss of personal
privacy. The ideal solution set will require innovation that lowers the risk or perceived risk for individuals while
enabling the efficiency and quality of population health research.
The issue raised in population health research is a subset of the broader tension between the benefits
and protections for the individual and the benefits and protections for society where each group is interlinked.
Individuals influence a society and society influences individuals. A mutually satisfactory balance for individuals
and society is an iterative process that is usually achieved by policy and technology solutions. Some of the
solutions may be found within the domain of population health research and some of the solutions may come
from other domains with similar individual-society tensions. Most likely, the solution framework will need to
address key principles of inclusive governance and power sharing among key stakeholders and transparency
regarding the process of decision making and the information and processes used to make decisions.
Philosophies of social justice and human rights will need to be considered.

IV. POTENTIAL SOLUTIONS

Evolutionary Steps

Evolutionary steps involve making subtle, iterative advances from existing frameworks to finding the right
balance between data sharing and data privacy. Inter-institutional trust models among entities holding and
generating data and enabling that data to go through an intermediary to an end-user for research can be
managed through contractual agreements. These include business associate agreements, data services
agreements, data use agreements for limited data sets, and consent for sharing protected health information.
However, the need to execute one off agreements for each scenario can be cumbersome. Others have begun
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creating data repositories with IRB approval and participant consent to hold data for current and future
research opportunities as an alternative approach.

Disruptive Innovation Steps

Disruptive Innovation is a theory that has taken systems that are large, complicated and expensive, and
through various processes, simplified, increased efficiencies and cost effectiveness of this theory.35 Some
potential “disruptive innovations” to improve healthcare are listed below:
Options Other than Written Informed Consent Process. More disruptive solutions have included an “opt out”
vs. “opt in” research framework where persons who do not acknowledge that they do not want their health data
shared will be volunteering to have their data shared.36 Broad notification rather individual notification could be
used along with community consultation.37

Use of Privacy Standards Other than HIPAA. Another option is to use a privacy standard other than HIPAA.
For instance, a framework that obligates persons and entities who collect, access and disclose information to
adopt responsible data stewardship practices, regardless of whether or not data subjects have provided
consent and where privacy rests primarily on the data holders has been used in the telecommunications
industry.38 The Fair Information Practice Principles (“FIPPS”) includes providing a framework of policies
regarding openness and transparency; purpose specification; collection limitation and data minimization; use
limitations; individual participation and control; data quality and integrity; security safeguards and controls;
accountability and oversight; and remedies.39

Compensation Programs. Another option is to reduce the risk of harm for all involved through insurance
mechanisms. For instance, after lawsuits against vaccine companies and health care providers threatened to
reduce vaccine supply and vaccination rates, the National Vaccine Injury Compensation Program was created
in the 1980s.40 It had a framework that rare but anticipated serious adverse events could occur with vaccines.
It established a no-fault alternative to the traditional legal system for resolving vaccine injury petitions.41 A
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similar federal insurance structure could be created with health systems engaged in research with protected
health information where even with the best controls breaches can occur. The health systems can pay into
such a system and compensate individuals with the purchase of identity monitoring over time.
An alternative to paying claims after an event has occurred could be for health systems to offer identity
protection insurance for any person seeking care institutions and enabling persons to access identity
preservation services if a breach occurs through these commercial entities.

V. CONCLUSION
In 1979, The Belmont Report laid out the Ethical Principles for Human Research.42 These included
respect for persons, beneficence and justice.43 This framework still holds as we think about the acceleration of
population health research to create a social good for all. Respect for persons includes understanding their
personal privacy setting and to come to some shared decisions about when to share and not share
information. Beneficence focuses of minimizing risk of harm in situations where all the outcomes are not
known. Justice involves not having a single group take the risk for all that would benefit. In the end, there is
significant promise in improving the value of health and in reducing suffering with the advanced technologies
that generate information about the mechanisms leading to health. We still have to find the right way to
advance the “commons” of population health research in order to provide health equity while maintaining the
highest level of respect and responsibility for persons who volunteer to be part of population health research.
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